Valuation: Bayer AG

Market Cap 49.24B 56.29B 45.42B 41.95B 79.59B 5,369B 80.93B 543B 213B 2,645B 211B 207B 9,092B P/E 2026 *
21.2x
P/E 2027 * 15.9x
Enterprise Value 80.99B 92.59B 74.7B 68.99B 131B 8,830B 133B 893B 350B 4,350B 348B 340B 14,955B EV / Sales 2026 *
1.78x
EV / Sales 2027 * 1.67x
Free-Float
100%
Yield 2026 *
0.47%
Yield 2027 * 1.27%
1 day-1.14%
1 week-6.07%
Current month+3.53%
1 month+41.70%
3 months+24.93%
6 months+28.91%
Current year+35.42%
1 week 49.36
Extreme 49.36
53.78
1 month 35.59
Extreme 35.59
53.92
Current year 32.96
Extreme 32.96
53.92
1 year 24.8
Extreme 24.805
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 59 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 66 2022-03-31
Director/Board Member 60 2017-03-31
Date Insider Type Main position Quantity % Market Cap.
03-17Buy

Chairman

2,671 0.0003%
03-17Buy

Chief Executive Officer

21,050 0.0021%
03-17Buy

Director

1,900 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-1.14%-6.07%+80.42%+1.18% 56.29B
-2.33%-2.09%+50.33%+162.29% 1,060B
-0.82%-2.30%+62.97%+61.11% 619B
-0.73%-4.98%+27.22%+84.46% 438B
+0.33%-1.17%+27.98%+26.90% 333B
-0.02%-2.85%+25.27%+44.88% 282B
-3.89%-11.22%+20.78%+26.07% 267B
+0.66%-1.42%-29.26%-39.30% 218B
-0.06%-2.88%+20.98%+61.70% 196B
-3.72%-1.10%+13.35%+71.53% 161B
Average -0.92%-3.53%+30.00%+50.08% 363.02B
Weighted average by Cap. -0.57%-3.01%+35.98%+80.03%

Financials

2026 *2027 *
Net sales 45.55B 52.08B 42.02B 38.81B 73.63B 4,967B 74.87B 502B 197B 2,447B 196B 191B 8,412B 46.65B 53.34B 43.03B 39.74B 75.41B 5,087B 76.68B 514B 202B 2,506B 200B 196B 8,615B
Net income 2.15B 2.45B 1.98B 1.83B 3.47B 234B 3.53B 23.65B 9.29B 115B 9.21B 9.01B 396B 2.99B 3.42B 2.76B 2.55B 4.84B 326B 4.92B 32.98B 12.95B 161B 12.84B 12.56B 553B
Net Debt 31.75B 36.29B 29.28B 27.05B 51.32B 3,462B 52.18B 350B 137B 1,705B 136B 133B 5,862B 28.53B 32.62B 26.31B 24.3B 46.12B 3,111B 46.89B 314B 123B 1,532B 122B 120B 5,268B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,757
Date Price Change Volume
26-07-10 €50.12 -1.14% 3,328,484
26-07-09 €50.70 +2.14% 2,129,503
26-07-08 €49.64 -2.32% 2,727,869
26-07-07 €50.82 -0.70% 2,382,812
26-07-06 €51.18 -4.09% 3,683,731
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
50.12EUR
Average target price
54.28EUR
Spread / Average Target
+8.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BAYN Stock